A group of mental health experts from research, industry, regulatory bodies and with lived experience have proposed new agreed criteria to define the type of depression that current medications and therapies cannot treat effectively. The report aims to provide consistent definitions for future research, and especially for designing clinical trials for new medications, with the aim of helping to develop more tailored and effective treatments for people experiencing this difficult condition.
By
NIHR Maudsley BRC at 15 Dec 2021
A review looking at mental health care provided by phone and video call (remote care) during the COVID-19 pandemic has shown that many service users were able to continue accessing support but that the shift to remote care presented barriers to certain groups.
By
NIHR Maudsley BRC at 9 Dec 2021
A study funded by NIHR Maudsley BRC has shown that the onset of depression in adolescents is likely to have a negative impact on subsequent educational performance. Previous research has shown this relationship, but it has been difficult to understand the magnitude of this impact and describe it a way that could be meaningful to young people, families and staff within health and education settings.
By
NIHR Maudsley BRC at 6 Dec 2021
New research funded by the NIHR Maudsley Biomedical Research Centre has suggested that using neurofeedback to address self-blame in people experiencing non-anxious major depressive disorder (MDD) can help to lessen key symptoms.
By
NIHR Maudsley BRC at 3 Dec 2021
Dr Katherine S. Young is an NIHR Maudsley Biomedical Research Centre Lecturer based in the Social, Genetic & Developmental Psychiatry (SGDP) Centre at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London. Her background is in neuroscience, experimental and clinical psychology, and her current work focuses on depression (particularly symptoms of ‘anhedonia’) in adolescents.
By
NIHR Maudsley BRC at 26 Nov 2021
